跳至主要内容
临床试验/CTRI/2024/06/068989
CTRI/2024/06/068989尚未招募Unknown

Expression of MiRNAs, p-16, MSI and PDL-1 molecular markers in Cervical Cancer patients undergoing Chemoradiotherapy - NI

Institutional Intramural Funds Tata Memorial Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1) Biopsy proven squamous cell cancer of Cervix uteri.
  • 2) Patients with age more than 18 years or less than 80 years.
  • 3) ECOG (0,1,2)
  • 4) Patients amenable for curative intent treatment.
  • 5) Suitable for Brachytherapy boost.
  • 6) Have given their consent for the study.
  • 7) FIGO Stage II,III

排除标准

  • 1) Patients with distant metastasis
  • 2) Previous history of abdominal or pelvic radiotherapy / partial or total hysterectomy / neoadjuvant chemotherapy
  • 4) Severe medical condition impairing complete treatment delivery
  • 5) Immunocompromised states and psychological illness
  • 6) Patients planned only either for EBRT, or Brachytherapy
  • 7) Pregnant and lactating women

研究者

发起方
Institutional Intramural Funds Tata Memorial Centre

相似试验